Active	Status	Sponsor type	Region	Phase	Filter
3 Active 0 Inactive 3 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Zhao, Qingxia
NCT05242042: JT001 (VV116) for the Early Treatment of COVID-19	Terminated	2/3	381	RoW	JT001, VV116, Placebo	Shanghai JunTop Biosciences Co., LTD, Sponsor GmbH	Mild to Moderate COVID-19	03/23	03/23
NCT06560489: Pharmacokinetics and Efficacy of Multiple Dosing of LP-98 for Injection in HIV-infected Patients	Enrolling by invitation	1/2	40	RoW	Subjects will be randomly assigned to receive 1.25 mg, 2.5 mg, 5 mg, or 10 mg of LP-98.	Shanxi Kangbao Biological Product Co., Ltd., National Institute of Pathogen Biology， Chinese Academy of Medical Sciences	Hiv	01/25	05/25
NCT06771479: A Study Evaluating the Safety and Immunogenicity of MVA Strain Monkeypox Attenuated Live Vaccine	Not yet recruiting	1	120	NA	MVA strain monkeypox attenuated live vaccine (low dose), MVA strain monkeypox attenuated live vaccine (high dose), Placebo	Shanghai Institute Of Biological Products	Monkeypox	06/25	05/26